Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

Current therapies for autoimmune diseases rely on traditional immunosuppressive medications that expose patients to an increased risk of opportunistic infections and other complications. Immunoregulatory interventions that act prophylactically or therapeutically to induce antigen-specific tolerance...

Full description

Bibliographic Details
Main Authors: Bilate, Angelina M. (Author), Huang, Nai-Jia (Author), Li, Hojun (Author), Patterson, Heide C. (Author), Dougan, Stephanie K. (Author), Maruyama, Takeshi (Author), Pishesha, Novalia (Contributor), Wibowo, Marsha C (Contributor), Dhesycka, Rhogerry (Contributor), Bousbaine, Djenet (Contributor), Lodish, Harvey F (Contributor), Ploegh, Hidde (Contributor), Li, Zeyang,S.M.Massachusetts Institute of Technology (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Biology (Contributor)
Format: Article
Language:English
Published: National Academy of Sciences (U.S.), 2018-01-18T17:23:38Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items